Notification report

Full notification file

General information

Notification Number

Member State to which the notification was sent

Date of acknowledgement from the Member State Competent Authority

Title of the Project
Evaluation of Field Safety and Efficacy by Serology in Broilers in Hungary after Vaccination via the Subcutaneous Route with a Herpes Virus of Turkey Vaccine Carrying a VP2 Gene of Infectious
Bursal Disease (Poulvac Procerta HVTIBD)

Proposed period of release:
01/05/2021 to 31/05/2022

Name of the Institute(s) or Company(ies)
Klifovet AG, Geyerspergerstra├če 27
80689 Munich

3. Is the same GMO release planned elsewhere in the Community?
Spain; Italy; Hungary;

Has the same GMO been notified elsewhere by the same notifier?

GMO characterization

GMO is a:
DNA Virus

Identity of the GMO:
The GMO consists of a live cell-associated Herpes of Turkey (HVT) strain FC-126 that has been genetically modified by inserting the VP2 gene of infectious bursal disease virus (IBDV) into the HVT strain FC-126 genome.

Information relating to the recipient or parental organisms from wich the GMO is derived
Common NameGenusSpeciesSubspeciesStrainPathovar
HVTMardivirusMeleagrid herpes virus 1-FC 126 strain-

European Commission administrative information

Consent given by the Member State Competent Authority:
Not known